• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人工胰腺长期适应性的多变量学习框架。

Multivariate learning framework for long-term adaptation in the artificial pancreas.

作者信息

Shi Dawei, Dassau Eyal, Doyle Francis J

机构信息

Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard University Cambridge MA 02138.

出版信息

Bioeng Transl Med. 2018 Nov 12;4(1):61-74. doi: 10.1002/btm2.10119. eCollection 2019 Jan.

DOI:10.1002/btm2.10119
PMID:30680319
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6336673/
Abstract

The long-term use of the artificial pancreas (AP) requires an automated insulin delivery algorithm that can learn and adapt with the growth, development, and lifestyle changes of patients. In this work, we introduce a data-driven AP adaptation method for improved glucose management in a home environment. A two-phase Bayesian optimization assisted parameter learning algorithm is proposed to adapt basal and carbohydrate-ratio profile, and key feedback control parameters. The method is evaluated on the basis of the 111-adult cohort of the FDA-accepted UVA/Padova type 1 diabetes mellitus simulator through three scenarios with lifestyle disturbances and incorrect initial parameters. For all the scenarios, the proposed method is able to robustly adapt AP parameters for improved glycemic regulation performance in terms of percent time in the euglycemic range [70, 180] mg/dl without causing risk of hypoglycemia in terms of percent time below 70 mg/dl.

摘要

长期使用人工胰腺(AP)需要一种能够随着患者的生长、发育和生活方式变化进行学习和适应的自动胰岛素输送算法。在这项工作中,我们引入了一种数据驱动的AP适应方法,以改善家庭环境中的血糖管理。提出了一种两阶段贝叶斯优化辅助参数学习算法,用于调整基础胰岛素和碳水化合物比例曲线以及关键反馈控制参数。该方法基于美国食品药品监督管理局(FDA)认可的UVA/帕多瓦1型糖尿病模拟器的111名成人队列,通过三种存在生活方式干扰和初始参数不正确的场景进行评估。对于所有场景,所提出的方法能够稳健地调整AP参数,以提高血糖调节性能,即处于正常血糖范围[70, 180]mg/dl的时间百分比,同时不会导致低血糖风险,即血糖低于70mg/dl的时间百分比。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bd5/6336673/3b67ddb39e4e/BTM2-4-61-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bd5/6336673/b28e7ca0a0be/BTM2-4-61-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bd5/6336673/90537e6b3ae6/BTM2-4-61-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bd5/6336673/67f98a3c2b35/BTM2-4-61-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bd5/6336673/713c92dc6465/BTM2-4-61-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bd5/6336673/f8d84a28d825/BTM2-4-61-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bd5/6336673/a7c689fa6647/BTM2-4-61-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bd5/6336673/51f4d33f8bab/BTM2-4-61-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bd5/6336673/0a512ebb2a00/BTM2-4-61-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bd5/6336673/aa0a8f40813c/BTM2-4-61-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bd5/6336673/d0458d7cdbc7/BTM2-4-61-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bd5/6336673/3b67ddb39e4e/BTM2-4-61-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bd5/6336673/b28e7ca0a0be/BTM2-4-61-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bd5/6336673/90537e6b3ae6/BTM2-4-61-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bd5/6336673/67f98a3c2b35/BTM2-4-61-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bd5/6336673/713c92dc6465/BTM2-4-61-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bd5/6336673/f8d84a28d825/BTM2-4-61-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bd5/6336673/a7c689fa6647/BTM2-4-61-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bd5/6336673/51f4d33f8bab/BTM2-4-61-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bd5/6336673/0a512ebb2a00/BTM2-4-61-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bd5/6336673/aa0a8f40813c/BTM2-4-61-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bd5/6336673/d0458d7cdbc7/BTM2-4-61-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9bd5/6336673/3b67ddb39e4e/BTM2-4-61-g011.jpg

相似文献

1
Multivariate learning framework for long-term adaptation in the artificial pancreas.人工胰腺长期适应性的多变量学习框架。
Bioeng Transl Med. 2018 Nov 12;4(1):61-74. doi: 10.1002/btm2.10119. eCollection 2019 Jan.
2
Long-term use of the hybrid artificial pancreas by adjusting carbohydrate ratios and programmed basal rate: A reinforcement learning approach.通过调整碳水化合物比例和程序化基础率长期使用混合人工胰腺:一种强化学习方法。
Comput Methods Programs Biomed. 2021 Mar;200:105936. doi: 10.1016/j.cmpb.2021.105936. Epub 2021 Jan 14.
3
In-silico evaluation of an artificial pancreas achieving automatic glycemic control in patients with type 1 diabetes.1 型糖尿病患者自动血糖控制的人工胰腺的计算机模拟评估。
Front Endocrinol (Lausanne). 2023 Jan 30;14:1115436. doi: 10.3389/fendo.2023.1115436. eCollection 2023.
4
The Efficacy of Basal Rate and Carbohydrate Ratio Learning Algorithm for Closed-Loop Insulin Delivery (Artificial Pancreas) in Youth with Type 1 Diabetes in a Diabetes Camp.闭环胰岛素输送(人工胰腺)中基础率和碳水化合物比例学习算法在糖尿病营中对 1 型糖尿病青少年的疗效。
Diabetes Technol Ther. 2020 Mar;22(3):185-194. doi: 10.1089/dia.2019.0270. Epub 2019 Oct 25.
5
Internal model control based module for the elimination of meal and exercise announcements in hybrid artificial pancreas systems.基于内部模型控制的模块,用于消除混合人工胰腺系统中的进餐和运动通知。
Comput Methods Programs Biomed. 2022 Nov;226:107061. doi: 10.1016/j.cmpb.2022.107061. Epub 2022 Aug 8.
6
Safe and Personalized Meal Bolus Calculator for Type-1 Diabetes Using Bayesian Optimization.使用贝叶斯优化的 1 型糖尿病安全个性化餐时推注计算器。
IEEE Trans Biomed Eng. 2023 May;70(5):1481-1492. doi: 10.1109/TBME.2022.3219370. Epub 2023 Apr 21.
7
Toward a Fully Automated Artificial Pancreas System Using a Bioinspired Reinforcement Learning Design: In Silico Validation.基于生物启发式强化学习设计的全自动人工胰腺系统:计算机模拟验证。
IEEE J Biomed Health Inform. 2021 Feb;25(2):536-546. doi: 10.1109/JBHI.2020.3002022. Epub 2021 Feb 5.
8
Adaptive Zone Model Predictive Control of Artificial Pancreas Based on Glucose- and Velocity-Dependent Control Penalties.基于葡萄糖和速度相关控制罚函数的人工胰腺自适应区域模型预测控制。
IEEE Trans Biomed Eng. 2019 Apr;66(4):1045-1054. doi: 10.1109/TBME.2018.2866392. Epub 2018 Aug 21.
9
Adaptive Control of an Artificial Pancreas Using Model Identification, Adaptive Postprandial Insulin Delivery, and Heart Rate and Accelerometry as Control Inputs.使用模型识别、自适应餐后胰岛素输注以及心率和加速度测量作为控制输入的人工胰腺自适应控制
J Diabetes Sci Technol. 2019 Nov;13(6):1044-1053. doi: 10.1177/1932296819881467. Epub 2019 Oct 9.
10
Incorporating Prior Information in Adaptive Model Predictive Control for Multivariable Artificial Pancreas Systems.在多变量人工胰腺系统的自适应模型预测控制中融入先验信息。
J Diabetes Sci Technol. 2022 Jan;16(1):19-28. doi: 10.1177/19322968211059149. Epub 2021 Dec 3.

引用本文的文献

1
Artificial Pancreas: The First 20 Years.人工胰腺:头20年
J Diabetes Sci Technol. 2025 Jul;19(4):875-882. doi: 10.1177/19322968251330920. Epub 2025 Jul 1.
2
design and validation of a time-varying PID controller for an artificial pancreas with intraperitoneal insulin delivery and glucose sensing.用于具有腹腔内胰岛素输送和葡萄糖传感功能的人工胰腺的时变PID控制器的设计与验证
APL Bioeng. 2023 May 23;7(2):026105. doi: 10.1063/5.0145446. eCollection 2023 Jun.
3
Effectiveness and safety of a model predictive control (MPC) algorithm for an artificial pancreas system in outpatients with type 1 diabetes (T1D): systematic review and meta-analysis.

本文引用的文献

1
The UVA/Padova Type 1 Diabetes Simulator Goes From Single Meal to Single Day.UVA/帕多瓦1型糖尿病模拟器从单餐模拟发展到单日模拟。
J Diabetes Sci Technol. 2018 Mar;12(2):273-281. doi: 10.1177/1932296818757747. Epub 2018 Feb 16.
2
Twelve-Week 24/7 Ambulatory Artificial Pancreas With Weekly Adaptation of Insulin Delivery Settings: Effect on Hemoglobin A and Hypoglycemia.每周调整胰岛素输注设置的12周全天动态人工胰腺:对糖化血红蛋白和低血糖的影响。
Diabetes Care. 2017 Dec;40(12):1719-1726. doi: 10.2337/dc17-1188. Epub 2017 Oct 13.
3
Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes.
1型糖尿病(T1D)门诊患者人工胰腺系统模型预测控制(MPC)算法的有效性和安全性:系统评价与荟萃分析
Diabetol Metab Syndr. 2022 Dec 9;14(1):187. doi: 10.1186/s13098-022-00962-2.
4
Minimal and Maximal Models to Quantitate Glucose Metabolism: Tools to Measure, to Simulate and to Run in Silico Clinical Trials.最小和最大模型量化葡萄糖代谢:用于测量、模拟和进行临床前临床试验的工具。
J Diabetes Sci Technol. 2022 Sep;16(5):1270-1298. doi: 10.1177/19322968211015268. Epub 2021 May 25.
5
: Year 2020 in review.2020年回顾。
Bioeng Transl Med. 2020 Aug 26;5(3):e10178. doi: 10.1002/btm2.10178. eCollection 2020 Sep.
6
Controlling the AP Controller: Controller Performance Assessment and Modification.控制接入点控制器:控制器性能评估与改进
J Diabetes Sci Technol. 2019 Nov;13(6):1091-1104. doi: 10.1177/1932296819877217. Epub 2019 Sep 27.
1型糖尿病青少年和成人在家使用混合闭环胰岛素输送系统的血糖结果
Diabetes Technol Ther. 2017 Mar;19(3):155-163. doi: 10.1089/dia.2016.0421. Epub 2017 Jan 30.
4
Toward a Run-to-Run Adaptive Artificial Pancreas: In Silico Results.迈向实时自适应人工胰腺:计算机模拟结果。
IEEE Trans Biomed Eng. 2018 Mar;65(3):479-488. doi: 10.1109/TBME.2017.2652062. Epub 2017 Jan 11.
5
"Learning" Can Improve the Blood Glucose Control Performance for Type 1 Diabetes Mellitus.“学习”可改善 1 型糖尿病患者的血糖控制效果。
Diabetes Technol Ther. 2017 Jan;19(1):41-48. doi: 10.1089/dia.2016.0328. Epub 2017 Jan 6.
6
Feasibility of Long-Term Closed-Loop Control: A Multicenter 6-Month Trial of 24/7 Automated Insulin Delivery.长期闭环控制的可行性:24/7 自动化胰岛素输送的多中心 6 个月试验。
Diabetes Technol Ther. 2017 Jan;19(1):18-24. doi: 10.1089/dia.2016.0333. Epub 2016 Dec 16.
7
Periodic zone-MPC with asymmetric costs for outpatient-ready safety of an artificial pancreas to treat type 1 diabetes.用于人工胰腺治疗1型糖尿病门诊就绪安全性的具有不对称成本的周期性区域-MPC
Automatica (Oxf). 2016 Sep;71:237-246. doi: 10.1016/j.automatica.2016.04.015. Epub 2016 Jun 1.
8
Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes.1型糖尿病患者使用混合闭环胰岛素输送系统的安全性。
JAMA. 2016 Oct 4;316(13):1407-1408. doi: 10.1001/jama.2016.11708.
9
Home Use of an Artificial Beta Cell in Type 1 Diabetes.1型糖尿病患者在家中使用人工β细胞
N Engl J Med. 2015 Nov 26;373(22):2129-2140. doi: 10.1056/NEJMoa1509351. Epub 2015 Sep 17.
10
Adjustment of Open-Loop Settings to Improve Closed-Loop Results in Type 1 Diabetes: A Multicenter Randomized Trial.调整开环设置以改善 1 型糖尿病的闭环结果:一项多中心随机试验。
J Clin Endocrinol Metab. 2015 Oct;100(10):3878-86. doi: 10.1210/jc.2015-2081. Epub 2015 Jul 23.